Background. No randomized trials have examined the effect of contact precautions or universal glove and gown use on adverse events. We assessed if wearing gloves and gowns during all patient contact in the intensive care unit (ICU) changes adverse event rates.
Healthcare-associated infections (HAIs) are an important cause of morbidity and mortality in hospitalized patients [1] but comprise only 1 type of adverse safety event experienced by hospitalized patients. Adverse events are unintended injuries resulting from or contributed to by medical or surgical care that are not due to an underlying condition [2] . Within hospital settings, approximately 1 in 4 patients experiences at least 1 adverse event [3] . Adverse events may result in temporary harm, prolonged hospitalization, permanent disability, or death [4] [5] [6] . The Office of the Inspector General reported that 27% of Medicare patients experienced an adverse event [7] . An estimated 15 000 Medicare patients per month will experience an adverse event that contributes to their death [7] . In addition, preventable adverse events cost the United States $6.7 billion each year [8] .
The Centers for Disease Control and Prevention (CDC) recommends use of contact precautions (glove and gown use prior to patient room entry) for patients colonized or infected with antibiotic-resistant bacteria to reduce transmission of these bacteria and subsequent HAIs [9] . However, contact precautions may increase the frequency of adverse events [10, 11] . Healthcare workers (HCWs) visit patients on contact precautions less often than other patients [12] [13] [14] . When contact precautions are used for all patients, the practice is called universal glove and gown use. Differences between contact precautions and universal glove and gown are few but include contact precautions causing delays in hospital admission from the emergency room or discharge from the hospital to a nursing home because of the need for a private room [15] [16] [17] . A cluster randomized trial among intensive care units (ICUs), Benefits of Universal Gloving and Gowning (BUGG), found that universal use of gloves and gowns decreased acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by 40% without impacting vancomycinresistant enterococci (VRE) acquisition rates [14] .
Contact precautions may cause psychological harm to patients [18, 19] , but physical harm remains unresolved. In a retrospective study, Stelfox et al reported twice the rate of overall adverse events and 7 times as many preventable adverse events in patients on contact precautions compared with patients not on contact precautions [11] . Within the ICU setting, Zahar et al reported a 1.5 times increase in rates of hypo-and hyperglycemia among patients on contact precautions [20] . In contrast, a recent case-crossover study on the use of contact precautions for patients with VRE found no overall difference in adverse events [10] .
A major limitation of these studies is that they could not completely account for greater severity of illness among patients on contact precautions. Patients identified with MRSA or VRE generally are more severely ill [21, 22] , which increases overall risk of adverse events. Moreover, some studies used unconventional definitions of adverse events including electrolyte imbalances or select types of events [11, 20, 23] . Thus, the role of contact precautions in patient adverse events remains unclear.
Within a cluster randomized trial of universal glove and gown use (universal use of contact precautions), we examined whether universal glove and gown use increased the rate of patient adverse events compared with usual care.
METHODS

Study Design
This was a secondary analysis of a 20-site cluster randomized trial in adult (≥18 years of age) ICUs across the United States (BUGG) with institutional review board approval [14] . Healthcare workers in ICUs randomized to the intervention donned gloves and gowns prior to all patient contact, whereas HCWs randomized to the control arm (usual care) did this only for patients known to be colonized or infected with antibioticresistant bacteria, per CDC guidelines [9] . Hospitals were recruited via the Society for Healthcare Epidemiology Research Network. The study period was January 2012 to October 2012.
The ICUs were pair-matched on 3-month baseline composite acquisition of MRSA or VRE and randomized to intervention or control group within pair-matches. During the study period, 10-14 patient charts per site were randomly selected (via random number generator) each month for review for adverse events (90 patients per site and 1800 patients overall). No historical data on adverse event rates were available. This study was approved by the University of Maryland School of Medicine Institutional Review Board (central IRB) and local IRBs for each of the 20 sites.
Recruitment and Eligibility Criteria
Individual patient charts were eligible for sampling and review if the patient stayed in the study ICU for at least 24 hours. Rates of adverse events seen in patients in the control arm (those not colonized or infected with antibiotic-resistant bacteria on ICU admission and not on contact precautions at any point in stay) were compared to rates for patients in the intervention arm (also not colonized or infected with antibiotic-resistant bacteria but on universal glove and gown). This allowed a randomized method to assess the effect of contact precautions on patients with similar characteristics.
Outcomes
The primary outcomes were counts of noninfectious and infectious adverse events. Adverse events were defined as "unintended physical injury resulting from or contributed to by medical care that requires additional monitoring, treatment, or hospitalization or that results in death," according to the Institute for Healthcare Improvement (IHI) Global Trigger Tool [2] . Events due to the patient's underlying condition were not recorded as adverse events. Infectious adverse events were defined as infections that occurred in the ICU but were not present or incubating on patient ICU admission (hospital-acquired infections). Infectious events were determined by 2 infectious disease physicians (D. J. M. and A. D. H.) by applying CDC National Healthcare Safety Network criteria. All other adverse events were classified as noninfectious. Rates of adverse events were expressed as the number of a specific ICU adverse event type divided by total person-time at risk (patient-specific ICU length of stay in days).
Adverse events were identified using the IHI Global Trigger Tool to conduct structured patient chart reviews [2] , which is designed for completion of chart review within 20 minutes. Ninety patient charts were reviewed at each site by a primary reviewer. Primary site reviewers were clinical research staff unaffiliated with study ICUs who were unaware of the secondary study question and hypothesis. Site reviewers received standardized inperson and webinar training on the IHI Global Trigger Tool. Prior to study period data collection, site reviewers received training with 10 standardized sample charts and an additional 10 reviews on patient charts from their own institution. Personalized feedback on training chart reviews was provided (by D. J. M.) to each of the site reviewers. Landrigan and colleagues have reported 81% agreement between reviewers and "gold standard" experienced reviewers [24] , and Sharek et al have reported interreviewer κ values ranging from 0.64 to 0.93 when the IHI Global Trigger Tool is used to identify adverse events [25] .
Secondary outcomes included rates of severe and preventable adverse events and type of harm categorized by physiological system affected [24] . Severity of adverse events was measured with a 5-point Likert scale (minimal, clinically significant, serious, life-threatening, fatal) as modified from the National Coordinating Council for Medication Error Reporting and Prevention severity index [2, 26] . Best fit to a category was assigned by final physician reviewers.
Site reviewers examined patient charts for adverse events and recorded events, severity and preventability ratings, a short description of the event(s), and discharge summary on a standardized, de-identified data extraction sheet sent to the study coordinator at the University of Maryland. Records were received and blinded to site identity, and 2 physician reviewers (A. D. H. and D. J. M.) independently reviewed the discharge summaries. Physician reviewers met to discuss and come to consensus on disagreements for occurrence of an adverse event (interphysician reviewer percentage of agreement of 89.5% prior to consensus). Reviewers determined whether each adverse event initially began before, during, or after the admission of interest. Analysis was restricted to adverse events that began during the index admission only, as events that began prior to or after the admission would not be the result of exposure to universal glove and gown.
Covariates
Covariates considered in the analysis included type of ICU (medical, surgical, or combined), hospital type (academic hospital with a medical school vs nonacademic), and size of ICU (continuous number of beds). In addition, as a measure of severity of illness, the Centers for Medicare and Medicaid (CMS) case mix index (CMI) for each hospital was obtained for the fiscal year prior to randomization (2011). The CMI is a measure of average patient acuity of a hospital [27, 28] . Studies of risk of patient falls among ICU patients have previously used hospital-level CMS CMI as a measure of average patient acuity [29] .
Statistical Power
We used a previously reported effect size for increase in adverse events due to contact precautions for an incidence rate ratio (IRR) of 2.4 among patients in universal glove and gown ICUs compared with patients in control ICUs [11] . We accounted for ICU-level clustering using an intraclass correlation coefficient of 0.001 [30] . For a 2-sided test with 5% type I error, with 900 patients in each arm of the study, we had 91% power to detect a 2.4 times higher rate of adverse events among patients in intervention ICUs compared with control ICUs.
Statistical Analysis
Randomization and the intervention occurred at the ICU level. Analysis of adverse events was conducted at the patient level, accounting for clustering by study site. Outcomes for this secondary analysis were unrelated to treatment allocation, so pair matching by baseline MRSA and VRE was not maintained for this study analysis. Noninfectious, infectious, preventable, and severe adverse event rates were modeled using Poisson mixedeffects, random-intercept models with ICU site included as the clustering variable and a compound symmetry covariance structure. The model offset was the log of patient ICU length of stay. Models of severe and preventable adverse event rates were constructed only for noninfectious adverse events. Covariates that meaningfully changed the log rate ratio estimate for universal glove and gown by approximately ≥10% owing to chance imbalances were included in the model. The covariates meeting this criterion included type of ICU, CMI, academic setting, and ICU bed size. Effect modification by biologically plausible variables such as CMI, academic hospital setting, and ICU bed size was considered by introducing interaction terms into the model and testing for statistical significance. The analysis of harm by physiological system affected was descriptive in nature. Counts of adverse events by intervention group were recorded and a bivariate analysis that did not account for clustering by ICU was performed using a χ 2 test.
RESULTS
Patients from intervention and control ICUs were similar with respect to ICU characteristics (Table 1) . However, patients in the intervention group were more likely to be admitted to medical ICUs (MICUs) and combined medical-surgical ICUs (MICU-SICUs) (60.0% and 30.0%, respectively) compared with control patients (50.0% in MICUs and 10.0% in MICUSICUs). Within the larger BUGG randomized trial, compliance with universal use of contact precautions on room entry was high in intervention ICUs (86.2% for gloves and 85.1% for gowns) [14] . In unclustered, descriptive analyses that did not examine rates given small absolute numbers of adverse events in each category, there was no significant increase in adverse events among intervention ICU patients for any physiological system (Table 2) . However, there were significantly fewer cardiovascular and surgical adverse events among intervention ICU patients. For example, 21 adverse events affecting the cardiovascular system of patients in intervention ICUs occurred vs 39 in control ICU patients (P = .02). Patients in intervention ICUs experienced 26 surgery-related adverse events vs 54 such events among patients in control ICUs (P = .001).
There was no statistically significant difference in unadjusted rate of noninfectious adverse events between patients in intervention ICUs compared with control ICU patients (46.3 per 1000 patient-days vs 56.5 per 1000 patient-days; IRR, 0.81; 95% confidence interval [CI], .48-1.36; P = .42). In unadjusted analysis, there was also no significant difference in infectious adverse events among patients in intervention ICUs (IRR, 0.57; 95% CI, .31-1.04; P = .07). No evidence of effect modification was found among covariates investigated.
Adjusted for type of ICU, CMS CMI, hospital setting, and ICU bed size, the rate of noninfectious adverse events among patients in intervention ICUs did not significantly differ from the rate of adverse events among patients in control ICUs (IRR, 0.91; 95% CI, .59-1.42; P = .68; Table 3 ). Similarly, we found no statistically significant difference in the rate of infectious adverse events (IRR, 0.75; 95% CI, .47-1.21; P = .24) when adjusting for clustering and confounding (Table 3) . Severe noninfectious adverse events were less common among patients in intervention ICUs than among patients in control ICUs, but the finding was not statistically significant (IRR, 0.82; 95% CI, .42-1.59; P = .56) after adjustment for the same covariates (Figure 1) . Universal glove and gown use was not significantly associated with preventable noninfectious adverse events (IRR, 1.26; 95% CI, .69-2.30; P = .46) (Figure 1 ).
DISCUSSION
We found that universal glove and gown use did not have an impact on overall rate of adverse events, including subtypes of infectious, noninfectious, preventable, or severe adverse events. We also observed fewer adverse events among patients in universal glove and gown ICUs for surgical and cardiovascular systems.
Previous observations of HCW behavior found that HCWs visit patients on contact precautions less often than those not on contact precautions [12] [13] [14] . However, despite observing 1 less HCW visit per hour in universal glove and gown ICUs (universal use of contact precautions) [14] , we found no evidence of increased risk of adverse events. Other changes to hospital flow with contact precautions but not universal glove and gown use (delayed admission or discharge) could still contribute to patients on contact precautions having more adverse events [15] [16] [17] .
To our knowledge, this is the first study to examine risk of adverse events in patients randomly exposed to universal glove and gown use. Past observational studies of contact precautions and adverse events have reported mixed results. Stelfox et al completed a retrospective cohort study of general medicine and congestive heart failure patients, finding 2.2 times as many adverse events and 7.0 times as many preventable adverse events among patients on contact precautions [11] . This difference may be explained by greater severity of illness among patients on contact precautions. Patients identified with MRSA or VRE generally have a greater severity of illness [21, 22] , which increases risk of adverse events. In contrast, our study excluded patients who would be on contact precautions to better examine the effect of universal glove and gown use, separate from severity of illness. Furthermore, the nonstandard definition of adverse event used by Stelfox et al included fluid and electrolyte imbalances as adverse events (without requirement for harm). Similar to our results, 2 studies that had more closely matched control groups reported no overall difference in the rate of adverse events [10, 23] . The observation that universal glove and gown use may result in fewer adverse events was unanticipated. Universal glove and gown use could potentially have led to a decrease in HAIs by serving as a barrier to acquiring new bacteria both through physical use of gloves and gowns as well as fewer HCW visits and better hand hygiene. A suggestion of improvement in noninfectious adverse events in patients cared for by universal glove and gown use would not be an obvious result of the physical use of gloves and gowns and, if real, would likely be due to a change in HCW behavior during the intervention (bundling activities or different level of attention to care). That noninfectious adverse events, which were less common with gown and glove use, were not considered preventable raises the question of whether the trend toward fewer adverse events with gown and glove was the result of random variation (as absolute number of preventable adverse events trended in the opposite direction). In contrast, our finding of no significant change in infectious adverse events is compatible with the primary BUGG study result of no significant reduction in composite VRE or MRSA despite the significant decrease reported for MRSA acquisition alone [14] . In addition, MRSA represents only 1 kind of infectious adverse event and, contaminated HCW clothing and hands may have a larger role in transmission of MRSA than for other organisms.
This study has some limitations. First, our study was powered to detect at least twice the rate of adverse events with universal glove and gown use, similar to the increase reported by Stelfox et al [11] . Despite having 4 times as many patients as Stelfox et al [11] , our study was not powered to detect a smaller increase in adverse events because of accounting for clustering at different sites. Clustering occurs when patients in the same ICU are more similar to one another than to patients in the other ICUs and results in a marked decrease in statistical power. However, our findings of lower or similar rates of adverse events suggest that there is no increased risk of adverse events from universal glove and gown use. Second, despite standardized training and 2-physician blinded review for final counts, differences in initial site chart review could have occurred. These differences would likely have been nondifferential in nature as site reviewers were unaware of adverse event reporting by other sites. Finally, despite being the gold standard for adverse event detection, the IHI Global Trigger Tool may have led to nondifferential underreporting of less severe adverse events [24] . These adverse events also would have been all-cause harms and not limited to those plausibly resulting from universal glove and gown use.
Our study has strengths including using a random sample of patient charts from a cluster randomized trial comparing universal glove and gown use to usual care. This, combined with exclusion of patients known to have antibiotic-resistant bacteria, helps minimize uncontrolled confounding that occurred in past observational studies on contact precautions. We also used a standard definition of adverse events, and final physician reviewers were blinded to the exposure status of patients during chart review for adverse events.
Patients in ICUs where HCWs donned gloves and gowns for all patient contact were no more likely to experience noninfectious or infectious adverse events than when HCWs did not use gloves and gowns. In fact, patients in universal glove and gown ICUs had fewer overall adverse events. Concerns that universal glove and gown use could contribute to adverse events should not be a limiting factor for implementation.
Notes
